TY - JOUR
T1 - Prevention of HIV infection for people who inject drugs
T2 - Why individual, structural, and combination approaches are needed
AU - Degenhardt, Louisa
AU - Mathers, Bradley
AU - Vickerman, Peter
AU - Rhodes, Tim
AU - Latkin, Carl
AU - Hickman, Matt
N1 - Funding Information:
We thank: Mukta Sharma, Mauro Guarinieri, and Tomas Zabransky for useful editorial comments and early discussions about the structure of the report; Erol Digiusto for a very thoughtful review and critique of this paper; Mary Kumvaj and Chiara Bucello for their efforts in undertaking systematic reviews, and help in locating hard-to-find papers; and Maria Prins for provision of additional data from the Amsterdam cohort for use in the mathematical modelling. LD was supported by an Australian National Health and Medical Research Council Senior Research Fellowship. PV was supported by an MRC new investigators award.
PY - 2010
Y1 - 2010
N2 - HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individual-level approaches to prevention of HIV infection; Review global and regional coverage of opioid substitution treatment, needle and syringe programmes, and antiretroviral treatment; Model the effect of increased coverage and a combination of these three approaches on HIV transmission and prevalence in injecting drug users; And discuss evidence for structural-level interventions. Each intervention alone will achieve modest reductions in HIV transmission, and prevention of HIV transmission necessitates high-coverage and combined approaches. Social and structural changes are potentially beneficial components in a combined-intervention strategy, especially when scale-up is difficult or reductions in HIV transmission and injection risk are difficult to achieve. Although further evidence is needed on how to optimise combinations of interventions in different settings and epidemics, we know enough now about which actions are effective: The challenge is to deliver these well and to scale.
AB - HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individual-level approaches to prevention of HIV infection; Review global and regional coverage of opioid substitution treatment, needle and syringe programmes, and antiretroviral treatment; Model the effect of increased coverage and a combination of these three approaches on HIV transmission and prevalence in injecting drug users; And discuss evidence for structural-level interventions. Each intervention alone will achieve modest reductions in HIV transmission, and prevention of HIV transmission necessitates high-coverage and combined approaches. Social and structural changes are potentially beneficial components in a combined-intervention strategy, especially when scale-up is difficult or reductions in HIV transmission and injection risk are difficult to achieve. Although further evidence is needed on how to optimise combinations of interventions in different settings and epidemics, we know enough now about which actions are effective: The challenge is to deliver these well and to scale.
UR - http://www.scopus.com/inward/record.url?scp=77955057113&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955057113&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(10)60742-8
DO - 10.1016/S0140-6736(10)60742-8
M3 - Review article
C2 - 20650522
AN - SCOPUS:77955057113
SN - 0140-6736
VL - 376
SP - 285
EP - 301
JO - The Lancet
JF - The Lancet
IS - 9737
ER -